VR Logo

ChromaDex Corporation (CDXC) download report


Healthcare | Biotechnology & Pharma Research

ChromaDex Corporation (CDXC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products.

IPO Date: 15-Jul-2008

Co-Founder & Exec. Chairman: Mr. Frank Louis Jaksch Jr.

CEO & Director: Mr. Robert N. Fried

Listing: NASDAQ: CDXC

Country: United States

Headquarters: Los Angeles, CA

Website: https://www.chromadex.com

Key Facts

Market cap: $122.32 Mln

Revenue (TTM): $35.02 Mln

Earnings (TTM): $-27.49 Mln

Cash: $20.79 Mln

Total Debt: $4.66 Mln

Insider's Holding: 39.99%

Liquidity: Low

52 Week range: $1.51 - 10.54

Shares outstanding: 68,334,600

10 Years Aggregate:

  • CFO: $-107.57 Mln
  • EBITDA: $-143.16 Mln
  • Net Profit: $-151.06 Mln

Stock Performance

Time Period ChromaDex (CDXC) S&P BSE Sensex S&P Small-Cap 600
YTD-54.28-8.99-19.23
1 month-5.00-3.40-9.35
3 months-34.73-8.50-16.59
1 Year-82.040.89-17.36
3 Years-28.3610.415.90
5 Years-15.0311.435.77
10 Years-1.8911.779.78
As on 30-Jun-2022
Year ChromaDex (CDXC) S&P Small-Cap 600 S&P BSE Sensex
2021-22.0825.2721.99
202011.379.5715.75
201925.6620.8614.38
2018-41.50-9.705.87
201777.6411.7327.91
2016-9.5624.741.95
201538.48-3.36-5.03